Dr. Caroline Augusto Barros is a biologist with a degree in Biology (2015) and a master's in Molecular and Cellular Biology (2017) from the Federal University of the State of Rio de Janeiro (UNIRIO). She also holds a Ph.D. in Biochemistry and Molecular Biology from the Federal Institute of Rio de Janeiro (IFRJ, 2022). Her academic career is dedicated to biochemistry and biotechnology, with a focus on macromolecular chemistry. Since 2013, Dr. Barros has been researching lactoferrin, examining its structural stability and biological potential. During her doctoral studies, she began investigating the interaction between lactoferrin and the prion proteins, evaluating its antiprion potential. Currently, she is expanding her research to explore lactoferrin’s role in other neurodegenerative diseases.
Dr. Caroline Augusto Barros is a biologist with a degree in Biology (2015) and a master's in Molecular and Cellular Biology (2017) from the Federal University of the State of Rio de Janeiro (UNIRIO). She also holds a Ph.D. in Biochemistry and Molecular Biology from the Federal Institute of Rio de Janeiro (IFRJ, 2022). Her academic career is dedicated to biochemistry and biotechnology, with a focus on macromolecular chemistry. Since 2013, Dr. Barros has been researching lactoferrin, examining its structural stability and biological potential. During her doctoral studies, she began investigating the interaction between lactoferrin and the prion proteins, evaluating its antiprion potential. Currently, she is expanding her research to explore lactoferrin’s role in other neurodegenerative diseases.